Related Experiment Video
Updated: Sep 23, 2026

Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
Published on: February 19, 2020
Myocardial tissue velocity reduction is correlated with clinical neurologic severity in myotonic dystrophy
Kevin C Fung1, Alistair Corbett, Leonard Kritharides
1Department of Cardiology, Concord Hospital, University of Sydney, Hospital Road, Concord, New South Wales 2139, Australia.
Abstract:
About 15% of patients with myotonic dystrophy (MD) die of ventricular arrhythmias, but few have documented left ventricular (LV) dysfunction and heart failure. This study prospectively evaluated a group of patients with MD without known heart failure to assess whether there is subclinical impairment of LV contractility using conventional 2-dimensional echocardiography and tissue Doppler imaging, and to correlate any abnormalities found with the degree of neurologic severity and cytosine-thymine-guanine trinucleotide repeat length. Twenty-two patients with MD without known heart failure were evaluated and compared with 22 healthy, age-matched controls. The patients with MD and control subjects did not differ with respect to LV ejection fraction (60 +/- 5% vs 60 +/- 4%, respectively, p = 0.86). However, peak systolic velocities were significantly lower in subjects with MD compared with controls in the basal lateral (6.1 +/- 2.6 vs 8.2 +/- 2.0 cm/s, p <0.005), basal septal (5.0 +/- 1.1 vs 6.3 +/- 1.1 cm/s, p <0.0003), and mitral annulus-lateral segments (7.6 +/- 1.9 vs 9.2 +/- 1.9 cm/s, p = 0.007). Mean LV velocities were also lower in subjects with MD (6.2 +/- 1.3 vs 7.5 +/- 1.1 cm/s, p <0.002). In subjects with MD, the peak systolic velocities correlated inversely with neurologic severity (r = -0.51, p = 0.014) but not with trinucleotide repeat length. In conclusion, patients with MD without known heart failure were found to have reduced myocardial tissue velocities; the degree of velocity reduction correlated with their neurologic severity.
Insights
Patients with myotonic dystrophy (MD) show reduced heart muscle movement (myocardial tissue velocities) even without diagnosed heart failure. This impairment correlates with increased neurologic severity.
Area of Science:
- Cardiology
- Neurology
- Genetics
Background:
- Myotonic dystrophy (MD) is associated with a 15% mortality rate from ventricular arrhythmias.
- Left ventricular (LV) dysfunction and heart failure are infrequently documented in MD patients.
- Subclinical cardiac impairment in MD warrants investigation.
Purpose of the Study:
- To prospectively assess subclinical left ventricular (LV) contractility impairment in MD patients without known heart failure.
- To evaluate LV function using echocardiography and tissue Doppler imaging.
- To correlate cardiac abnormalities with neurologic severity and CTG trinucleotide repeat length.
Main Methods:
- Prospective evaluation of 22 MD patients without known heart failure and 22 age-matched healthy controls.
- Conventional 2-dimensional echocardiography and tissue Doppler imaging were employed.
- Analysis included LV ejection fraction, peak systolic velocities, and mean LV velocities.
Main Results:
- No significant difference in LV ejection fraction between MD patients and controls (p = 0.86).
- Significantly lower peak systolic velocities in MD patients compared to controls in basal lateral, basal septal, and mitral annulus-lateral segments (p < 0.005).
- Reduced mean LV velocities observed in MD patients (p < 0.002).
- Peak systolic velocities inversely correlated with neurologic severity (r = -0.51, p = 0.014) but not trinucleotide repeat length.
Conclusions:
- MD patients without known heart failure exhibit reduced myocardial tissue velocities.
- The degree of myocardial velocity reduction is associated with neurologic severity in MD.
- Tissue Doppler imaging can detect subclinical cardiac impairment in MD.
More Related Videos
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Alterations in Muscle Tone lll
Pathophysiology of Cardiac Performance
Myocarditis II: Clinical Features and Diagnostic Tests

